| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |